Skip to content

Acute Nutritional Ketosis in VLCAD Deficiency: testing the metabolic basis for therapeutic use

Acute Nutritional Ketosis in VLCAD Deficiency: testing the metabolic basis for therapeutic use - Acute Nutritional Ketosis in VLCADD

Status
Active, not recruiting
Phases
Phase 2
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON44949
Enrollment
6
Registered
2015-03-24
Start date
2016-04-01
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

metabolic disease VLCADD

Interventions

None listed

Sponsors

Universitair Medisch Centrum Groningen
Lead Sponsor

Eligibility

Age
12 Years to 99 Years

Inclusion criteria

Inclusion criteria: * Confirmed VLCADD by genetic profiling * age: 16-65

Exclusion criteria

Exclusion criteria: * contra indications for MRI studies (assessed by standardised questionnaire as previously used in METc 08-267/K. Such as metal implants, vascular clips, eye-implants, metal particles in the eye, tattoos containing iron oxide, suspected pregnancy, refusal to be informed of strucural brain abnormalities that could be detected) * inability to perform bicycle exercise. * recent episode of rhabdomyolysis, or treatment for acute renal failure in the past 2 months. * intercurrent illness which may influence exercise tolerance (anaemia, musculoskeletal injury, or other undiagnosed illness under investigation). * known coronary artery disease, positive history for angina, or changes on ECG suggestive of previous ischaemia without a negative stress test. * insulin-dependent diabetes mellitus. * loss of, or an inability to give informed consent. * pregnancy or current breastfeeding, or females not taking the oral contraceptive pill * any other cause which in the opinion of the investigators, may affect the volunteers ability to participate in the study

Design outcomes

Primary

MeasureTime frame
To investigate: 1. the potential of a novel dietary substrate preparation to enhance muscle mitochondrial function in VLCADD via acute nutritional ketosis. 2. if tri-citric acid cycle substrate supply in muscle of patients with VLCADDis boosted by acute nutritional ketosis.

Secondary

MeasureTime frame
nvt

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)